Author

John M. Hickey

University of KansasORCID 0000-0002-9231-6568Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

John M. Hickey3 papers · Roslin Institute

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Charles Richardson· 1 shared David B. VolkiniD· 1 shared Greta Van SlykeiD· 1 shared Hans Lien· 1 shared Harry KleanthousiD· 1 shared Jennifer DoeringiD· 1 shared Katherine BermaniD· 1 shared Kawaljit KauriD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Charles Richardson

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyHuman Vaccines & ImmunotherapeuticsPeer-reviewedAug 1, 2023

Effects of aluminum-salt, CpG and emulsion adjuvants on the stability and immunogenicity of a virus-like particle displaying the SARS-CoV-2 receptor binding domain (RBD)

Ozan S. Kumru, Sakshi Bajoria, Kawaljit Kaur…·David B. Volkin

This paper evaluates the stability and immunogenicity of a SARS-CoV-2 RBD VLP vaccine candidate formulated with different adjuvants and finds that AP and AH adjuvants provide comparable immunogenicity to AV, with AP showing higher neutralizing titers.

5 citations

mouseproteomics

𝕏 PostBluesky